Christopher L Bowlus MD

Inflammatory Bowel Disease

Lena Valente Professor and Chief Division of Gastroenterology and Hepatology UC Davis School of Medicine

4150 V StSte 3500Sacramento, CA 95817
Phone+1 916-734-3751
Fax+1 916-734-7908

Dr. Bowlus is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bowlus' full profile Already have an account?

Education & Training

Yale-New Haven Medical CenterFellowship, Gastroenterology, 1993 - 1996
University of California Davis HealthResidency, Internal Medicine, 1990 - 1993
Saint Louis University School of MedicineClass of 1990

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1991 - 2027
CT State Medical License 1993 - 1999
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow (FAASLD) American Association for the Study of Liver Disease
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017

Clinical Trials

Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
COMPLETED
PHASE1, PHASE2
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
TERMINATED
PHASE2
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
COMPLETED
PHASE3

Publications & Presentations

PubMed

Symptom burden is associated with health-related quality of life in symptomatic adults with primary sclerosing cholangitis.
Donna M Evon, Kaya Merkler, Chelsea Anderson, Sasha Deutsch-Link, Rachel Gomel
Hepatology Communications. 2026-09-01
Response to Commentary on "Impact of Disease-Specific Treatment and NSBBs on Risk of PVT in Cirrhotic Patients With HCV or PBC".
Humberto C Gonzalez, Stuart C Gordon, Sheri Trudeau, Trueman Wu, Lora Rupp
Liver International. 2026-09-01
Fatigue and Cognitive Impairment in Adults With Primary Sclerosing Cholangitis: Results From Concept Elicitation Interviews.
Donna M Evon, Kaya Merkler, Laura Mkumba, Nicole Lucas, Lauren Wright
Liver International. 2026-09-01

Lectures

2013 UC Davis Update in Gastroenterology and Hepatology
UC Davis Health System, Monterey, California - 8/24/2013
31st Annual UC Davis Infectious Diseases Conference,2013
UC Davis Health System, Sacramento, California - 2/1/2013
2012 Update in Gastroenterology & Hepatology for the Primary Care Practitioner
UC Davis Health System, Olympic Valley, California - 8/18/2012

Press Mentions

FDA Approves Lynavoy for PBC-Associated PruritusMarch 23rd, 2026
Reduction in Serum IL-31 with Linerixibat May Be Linked to Pruritus Improvement in PBCNovember 17th, 2025
Livdelzi Maintains Benefits for up to 3 Years in PBC: Phase 3 DataNovember 12th, 2025

Grant Support

Oxidative Mutagenesis:Iron, Ascorbic Acid And GenesNational Institute Of Environmental Health Sciences2001–2002
Cloning Of The Hemochromatosis LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2000
Cloning Of The Hemochromatosis LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1997